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INTRODUCTION
Behcet’s disease (BD) is a chronic and multisystemic in-
flammatory disease of multifactorial etiology, involving both
infectious and genetic factors (1). The clinical major symp-
toms of BD in Korean patients are oral ulcers (98.8%), skin
lesions (84.3%), genital ulcers (83.2%), ocular lesions (50.9%),
and minor symptoms including articular symptoms (38.4%),
gastrointestinal symptoms (7.3%), neurological symptoms
(4.6%), epididymitis (0.6%), and vascular symptoms (1.8%)
(2). This wide range of clinical symptoms of BD probably
reflects different genetic backgrounds. 
Intercellular adhesion molecule-1 (ICAM-1, CD54) is
expressed on endothelial cells and various other cells and its
expression is increased during inflammation. ICAM-1 is a
member of the immunoglobulin superfamily and is a ligand
of macrophage-1 antigen (Mac-1;  M 2, CD11b/CD18) and
lymphocyte function associated antigen-1 (LFA-1;  L 2,
CD11a/CD18) (3). It is also involved in leukocyte migra-
tion into sites of inflammation and T-cell receptor-mediated
activation of resting T cells (4). 
ICAM1 gene (OMIM 147840) is located on chromosome
19p13.3-13.2 with polymorphisms of K29M, G241R,
K469E, A496T, and G1838A in the 3 UTR (5, 6). Single
base polymorphisms causing amino acid substitutions were
identified for ICAM1 at codon 241 in exon 4 (GGG AGG;
Gly Arg) for the Ig-like domain 3, the binding site of
Mac-1, and at codon 469 in exon 6 (AAG GAG; Lys
Glu), which codes for the Ig-like domain 5 (7). BD patients
were evaluated for the levels of both soluble and tissue ICAM-
1 and it has been hypothesized that the two mutations,
G241R and K469E, result in more effective binding of
ICAM1 to Mac-1 and LFA-1, thereby enhancing the inflam-
matory response (8). Both Mac-1 and LFA-1 binding site
mutations might be involved in some of the inflammation
events responsible for BD. While the pathogenic role of
these polymorphisms is unknown, an association has been
found with inflammatory diseases such as Behcet’s disease
in Jordanian or Palestinian populations (9), giant cell arteri-
tis (10), rheumatoid arthritis (11), inflammatory bowel dis-
ease (12), and chronic renal allograft failure (13).
In this study, we investigated whether ICAM1 gene poly-
morphisms in Korean BD patients are associated with dif-
ferent clinical subsets of BD.
MATERIALS AND METHODS
Patients with BD were recruited from the Behcet’s Dis-
ease specialty clinic of Severance Hospital, Yonsei Universi-
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Intercellular adhesion molecule-1 (ICAM-1) is expressed on vascular endothelial
cells and its expression increases during the inflammatory response in patients
with active Behcet’s disease (BD). The ICAM1 gene mutations are associated
with BD in Caucasians, but clinical features of the mutation phenotype are un-
known. We analyzed ICAM1 polymorphisms in Korean BD patients to determine
if there was an association between particular mutations and clinical symptoms.
The prevalence of ICAM1R241G and ICAM1K469E polymorphisms was deter-
mined among 197 patients with BD and 248 healthy controls using BsrG1 and
BstU1 PCR-RFLP. The frequency of both genotypes ICAM1469*K/*E and ICAM-
1469*E/*E was significantly higher in BD patients compared with controls (66.0%
vs 52.4%, p=0.004, OR=1.28, 95% CI 1.08-1.50) and the allele frequency of
ICAM1469*E was higher in patients with skin lesions (0.41), genital ulcers (0.41),
vasculitis (0.43), ocular lesions (0.41) and arthritis (0.39) than in controls (0.31).
Only one heterozygote, ICAM1241G/R, was detected in BD patients but the
ICAM1241*R mutation was not found in any of the 248 healthy controls. These
results show that the ICAM1 mutation is associated with BD susceptibility, and
is another genetic risk factor for BD among the Korean population. 
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ty College of Medicine (Table 1). A total of 197 patients with
BD and 248 healthy controls without BD were enrolled.
The diagnosis of BD was made according to the established
clinical criteria of the International Study Group Behcet’s
Disease (14) and the revised Shimizu’s classification (15).
After obtaining informed consent, blood samples were col-
lected and genomic DNA was extracted from peripheral
blood leukocytes with a QiaAmp Blood kit (Qiagen, Valen-
cia, CA, U.S.A.).
The ICAM1G241R polymorphism was detected by BsrGI
PCR-RFLP (New England Biolabs, Beverly, MA, U.S.A.)
(16, 17). The ICAM1K469E polymorphism was analyzed
by BstUI PCR-RFLP (New England Biolabs, Beverly, MA,
U.S.A.) (17, 18). 
For statistical analysis of the data, the SAS program (v 8.0e)
was used.
RESULTS
The distribution of the ICAM1469*E polymorphism dif-
fered significantly between patients and healthy controls.
The frequency of both genotypes ICAM1469*K/*E and
ICAM1469*E/*E was significantly higher in BD patients
than in controls (66.0% vs 52.4%, p=0.004, OR=1.28,
95% CI 1.08-1.50). The genotype and allele frequencies of
ICAMK469E in patients and in controls are shown in Table
2. The frequency of ICAM1469*E was higher in patients
with skin lesions (0.41), genital ulcers (0.41), vasculitis (0.43),
ocular lesions (0.41), and arthritis (0.39) than in controls
(0.31). The disease duration, age at onset of BD, sex distribu-
tion, duration of follow-up, and the use of drugs did not dif-
fer between both genotypes of patients carrying ICAM1469E.
Only one heterozygote ICAM1241G/R was detected in BD
patients and the ICAM1241*R mutation was not found
among healthy Korean controls. The heterozygote was found
in a 56-yr old man with a 12-yr history of the disease who
presented with ocular lesions and had a genotype of ICAM-
1469*E/*E. Our results show that the ICAM1469*E poly-
morphism is associated with BD, whilst the ICAM1241*R
polymorphism is rare among Koreans.
DISCUSSION
Association between ICAM1 gene mutations and BD
depends on ethnic origins (Table 3). The frequency of ICAM-
1469*E was higher in Korean patients with BD than in
controls, Palestinians, and Jordanians, while the frequency of
ICAM1241*R was higher in Italians (9, 19). The ICAM1
gene has also been associated with rheumatoid arthritis (RA)
in Italian patients. ICAM1241R was associated with RA
Female/Male 96/101 (49/51)
Mean age SD 40 10 yr
Mean disease duration SD 11 7 yr
Major symptoms
Oral ulcers 96/101 197 (100.0)
Skin lesions 88/98 186 (94.4)
Genital ulcers 87/80 167 (84.8)
Ocular lesions 74/77 151 (76.6)
Minor symptoms
Arthritis 57/57 114 (57.9) 
Vasculitis 4/40 44 (22.3)
Central nervous system 7/4 11 (5.6)
Gastrointestinal lesions 4/7 11 (5.6)
Female/Male
No.
No. (%)
Table 1. Demographic and clinical features of Korean patients
with BD
No.  *K/*K (%) *K/*E (%) *E/*E (%) *E p value OR 95% CI
Table 2. Genotype and allele frequencies of ICAM1K469E in Korean patients with BD and in controls
CNS, central nervous system.
p value, patients with ICAM1469*E positive vs controls with ICAM1469*E positive; OR, odds ratio; CI, confidence interval; ns, not significant.
Controls 248 118 (47.6) 107 (43.1) 23 (9.3) 0.31
All patients 197 67 (34.0) 100 (50.8) 30 (15.2) 0.41 0.004 1.28 1.08-1.50
skin lesions 186 61 (32.8) 96 (51.6) 29 (15.6) 0.41 0.002 1.29 1.10-1.52
without  11 6 (54.5) 4 (36.4) 1 ( 9.1) 0.32 ns
genital ulcers 167 56 (33.5) 84 (50.3) 27 (16.2) 0.41 0.004 1.26 1.08-1.47
without  30 11 (36.7) 16 (53.3) 3 (10.0) 0.35 0.002 1.89 1.26-2.86
ocular lesions  151 50 (33.1) 78 (51.6)  23 (15.2) 0.41 0.001 1.30 1.12-1.52
without  46 17 (34.8) 22 (50.0) 7 (15.2) 0.40 ns
vasculitis  44 14 (31.8) 22 (50.0) 8 (18.2) 0.43 0.053 1.10 1.00-1.21
without 153 53 (34.6) 78 (51.0) 22 (14.4) 0.40 0.011 1.22 1.05-1.42
arthritis 114 38 (33.3) 63 (55.3) 13 (11.4) 0.39 0.011 1.20 1.05-1.38
without  83 29 (34.9) 37 (44.6) 17 (20.5) 0.43 0.045 1.14 1.01-1.29
CNS  11 6 (54.5) 4 (36.4) 1 ( 9.1) 0.27 ns
without  186 61 (32.8) 96 (51.6) 29 (15.6) 0.41 0.002 1.29 1.10-1.52
gastrointestinal  11 2 (18.2) 7 (63.6) 2 (18.2) 0.50 ns
without  186 65 (34.9) 93 (50.5) 28 (15.1) 0.40 0.008 1.25 1.06-1.46ICAM1 Polymorphisms in Korean Behcets Disease Patients 417
but the allele and phenotype frequencies of ICAM1469E
did not differ significantly between RA patients and the
control group in the Italian study (11). The different results
might be due to different genetic backgrounds. The fre-
quency of ICAM1241*R showed a population variation in
contrast to the frequency of ICAM1469*E. The frequency
of ICAM1469*E is high in various countries (0.310-0.510).
While ICAM1241*R is quite rare in most populations, the
frequency of ICAM1241*R is higher in Europeans (0.031-
0.180) (10, 13, 16, 20) compared to in Koreans and Japanese
(0.000) (21) and Palestinians and Jordanians (0.015) (9). In
line with a previous report that suggested ICAM1469*E is
associated with inflammatory disease (22), our study shows
that the frequency of ICAM1469*E is higher in Korean BD
patients than in controls. We cannot draw any conclusion
on the association of ICAM1G241R with BD, as described
in Italian patients, because there was no case with ICAM1-
G241R among the Korean BD patients in this study. ICAM1
mutations, especially ICAM1469*E, might act as another
genetic susceptibility factor for BD in the Korean popula-
tion as well as the recently described MICA A6 allele and
HLA-B51 (23).
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